The estimated Net Worth of Eben Tessari is at least $3.54 Миллион dollars as of 1 September 2024. Eben Tessari owns over 6,463 units of Kiniksa Pharmaceuticals International Plc stock worth over $3,043,766 and over the last 3 years Eben sold KNSA stock worth over $497,119.
Eben has made over 11 trades of the Kiniksa Pharmaceuticals International Plc stock since 2021, according to the Form 4 filled with the SEC. Most recently Eben exercised 6,463 units of KNSA stock worth $157,309 on 1 September 2024.
The largest trade Eben's ever made was selling 17,500 units of Kiniksa Pharmaceuticals International Plc stock on 27 August 2024 worth over $470,925. On average, Eben trades about 3,611 units every 82 days since 2021. As of 1 September 2024 Eben still owns at least 125,052 units of Kiniksa Pharmaceuticals International Plc stock.
You can see the complete history of Eben Tessari stock trades at the bottom of the page.
Eben's mailing address filed with the SEC is , 23 OLD BOND STREET, THIRD FLOOR, LONDON, X0, W1S 4PZ.
Over the last 7 years, insiders at Kiniksa Pharmaceuticals International Plc have traded over $11,259,873 worth of Kiniksa Pharmaceuticals International Plc stock and bought 3,912,796 units worth $71,248,379 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., James E Deerfield Mgmt L.P.... и Bros. Advisors Lp667, L.P.B.... On average, Kiniksa Pharmaceuticals International Plc executives and independent directors trade stock every 22 days with the average trade being worth of $1,208,067. The most recent stock trade was executed by Eben Tessari on 1 September 2024, trading 6,463 units of KNSA stock currently worth $157,309.
Kiniksa Pharmaceuticals International Plc executives and other stock owners filed with the SEC include: